Heart failure drug passes Phase 2 trialsU-T San DiegoAn experimental heart failure drug being developed by Zensun Sci & Tech improved heart function in five Phase 2 clinical trials, the biotech company said today. Zensun, based in Shanghai, China, …
Non-Hodgkin lymphoma survival doubles since early 1970s – Medical Xpress
Scotsman |
Non-Hodgkin lymphoma survival doubles since early 1970s
Medical Xpress These vast improvements are largely thanks to better treatments – particularly the drug rituximab, which Cancer Research UK scientists laid the groundwork for with their early work into the immune system – and earlier diagnosis linked to improved … New treatments see blood cancer survival rates upScotsman |
Gay blood donation policy called improvement – CBC.ca
Winnipeg Free PressGay blood donation policy called improvementCBC.caThe group that represents gay, lesbian, bisexual and transgender people on P.E.I. says a new policy on blood donations for gay men is a good first step. Canadian Blood Services announ…
21-day R-CHOP regimen remains standard in diffuse B-cell lymphomas – Healio
21-day R-CHOP regimen remains standard in diffuse B-cell lymphomasHealioA 14-day regimen of rituximab plus CHOP failed to demonstrate improvement compared with the standard 21-day regimen in a cohort of patients with previously B-cell lymphomas, accord…
Celgene Announces US FDA Grants Priority Review for ABRAXANE® sNDA in … – National Post
Celgene Announces US FDA Grants Priority Review for ABRAXANE® sNDA in …
National Post … is also approved in Canada, India, European Union/European Economic Area (EU/EEA), South Korea, China, Australia, Bhutan, United Arab Emirates, Nepal, New Zealand, Japan, Russia, Sri Lanka, and Argentina for the treatment of metastatic breast … |
Celgene Announces US FDA Grants Priority Review for ABRAXANE(R) sNDA in … – MarketWatch (press release)
Celgene Announces US FDA Grants Priority Review for ABRAXANE(R) sNDA in …MarketWatch (press release)… is also approved in Canada, India, European Union/European Economic Area (EU/EEA), South Korea, China, Australia, Bhutan, United Arab Emirates, Ne…
Celgene Announces US FDA Grants Priority Review for ABRAXANE(R) sNDA in … – Wall Street Journal (press release)
Celgene Announces US FDA Grants Priority Review for ABRAXANE(R) sNDA in …Wall Street Journal (press release)… is also approved in Canada, India, European Union/European Economic Area (EU/EEA), South Korea, China, Australia, Bhutan, United Arab Emir…
Live in a high rise to live long – Times of India
Times of IndiaLive in a high rise to live longTimes of IndiaAccording to researchers at the University of Bern, Switzerland, the chances of dying from serious lung disease was 40 per cent more among residents who lived on the ground floor compared to t…
Organ donation – Paragould Daily Press
Organ donationParagould Daily PressTritia McGrew, RN, from Arkansas Methodist Medical Center Education Department, recently talked with PSD GT students in grades 9-12 about organ donation and how they have the power to save lives. She encouraged studen…
Intimacy or utility? Organ donation and the choice between palliation and … – 7thSpace Interactive (press release)
Intimacy or utility? Organ donation and the choice between palliation and …7thSpace Interactive (press release)Organ donation after brain death (DBD) provides the most important source for deceased organs for transplantation, both because of the numb…